Microfluidics devices are tiny chips that perform chemical analyses of extremely small volumes of fluids such as blood. Lab-on-a-chip devices, which often use microfluidics, are providing for earlier, more cost-effective disease detection and many other uses, from monitoring to treatment. The global microfluidics market is driven by the demand for low-volume sample analysis and high-throughput screening methodologies and has been fueled by the introduction of advanced technologies, such as lab-on-chip and the demand for in vitro diagnostics (IVDs).
This report contains market size and forecasts of Medical Microfluidic Devices in global, including the following market information:
Global Medical Microfluidic Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medical Microfluidic Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Medical Microfluidic Devices companies in 2021 (%)
The global Medical Microfluidic Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Microfluidic Devices include Roche, Abbott, Fluidigm Corporation, Johnson & Johnson, Siemens Healthcare, Agilent and Bio-Rad Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Microfluidic Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Microfluidic Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Microfluidic Devices Market Segment Percentages, by Type, 2021 (%)
Polymer
Glass
Silicon
Other
Global Medical Microfluidic Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Microfluidic Devices Market Segment Percentages, by Application, 2021 (%)
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other
Global Medical Microfluidic Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Microfluidic Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Microfluidic Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Medical Microfluidic Devices revenues share in global market, 2021 (%)
Key companies Medical Microfluidic Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Medical Microfluidic Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories